ES482806A1 - Procedimiento para la inversion de la configuracion en com- puestos opticamente activos - Google Patents

Procedimiento para la inversion de la configuracion en com- puestos opticamente activos

Info

Publication number
ES482806A1
ES482806A1 ES482806A ES482806A ES482806A1 ES 482806 A1 ES482806 A1 ES 482806A1 ES 482806 A ES482806 A ES 482806A ES 482806 A ES482806 A ES 482806A ES 482806 A1 ES482806 A1 ES 482806A1
Authority
ES
Spain
Prior art keywords
optically active
formula
configuration
compound
inverting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482806A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4335835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES482806(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES482806A1 publication Critical patent/ES482806A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Detergent Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Lasers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Procedimiento para la inversión de la configuración en compuestos ópticamente activos, de fórmula **(Fórmula)** donde Ar1 significa un resto mono- o policíclico, carbo- ó heterocíclico, que lleva como mínimo un anillo con carácter aromático, y que está enlazado con el átomo de oxígeno a través de un átomo de carbono de anillo, preferentemente del anillo con carácter aromático, R1 significa un resto hidrocarburo alifático, cicloalifático o aralifático, en caso dado sustituid, o de sus sales.
ES482806A 1978-07-28 1979-07-24 Procedimiento para la inversion de la configuracion en com- puestos opticamente activos Expired ES482806A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH814578 1978-07-28

Publications (1)

Publication Number Publication Date
ES482806A1 true ES482806A1 (es) 1980-04-16

Family

ID=4335835

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482806A Expired ES482806A1 (es) 1978-07-28 1979-07-24 Procedimiento para la inversion de la configuracion en com- puestos opticamente activos

Country Status (10)

Country Link
US (2) US4294966A (es)
EP (1) EP0007605B1 (es)
JP (2) JPS5520785A (es)
AT (1) ATE1547T1 (es)
AU (1) AU529335B2 (es)
CA (1) CA1132560A (es)
DE (1) DE2963675D1 (es)
DK (2) DK318379A (es)
ES (1) ES482806A1 (es)
FI (1) FI69051C (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
DE3229046A1 (de) * 1982-08-04 1984-02-16 Hoechst Ag, 6230 Frankfurt Verfahren zur umkehrung der konfiguration optisch aktiver verbindungen und optisch aktive zwischenprodukte dieses verfahrens
FR2536390B1 (fr) * 1982-11-22 1986-03-21 Synthelabo Isomere s du betaxolol, sa preparation et son application en therapeutique
JPH0739394B2 (ja) * 1985-05-30 1995-05-01 住友化学工業株式会社 含窒素複素環化合物およびそれを有効成分として含有する有害生物防除剤
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
US4920134A (en) * 1987-08-07 1990-04-24 Takeda Chemical Industries, Ltd. 2-O-pyrimidinyl glycerol derivatives
CA1338717C (en) * 1989-09-25 1996-11-12 Khashayar Karimian Nadolol
JP2002080435A (ja) * 2000-06-26 2002-03-19 Kanegafuchi Chem Ind Co Ltd ３−アミノ−２−ヒドロキシプロピオン酸誘導体の製造法
WO2002100841A1 (en) * 2001-05-23 2002-12-19 Kaneka Corporation PROCESSES FOR PRODUCING OXAZOLIDINONE DERIVATIVE OF ß-HYDROXYETHYLAMINE COMPOUND AND FOR PRODUCING ß-HYDROXYETHYLAMINE COMPOUND

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE585164C (de) 1932-06-11 1933-09-29 Helmut Legerlotz Dr Verfahren zur Umkehrung des Drehungssinnes von optisch aktiven Phenylalkaminen
US2446192A (en) * 1946-01-26 1948-08-03 Merck & Co Inc Preparation of threonine and derivatives thereof
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
GB1136919A (en) * 1965-06-16 1968-12-18 Ici Ltd Amines
US3994917A (en) * 1965-10-22 1976-11-30 Eli Lilly And Company Oxazolinium salt process
DE1720005A1 (de) * 1968-03-01 1971-05-19 Bayer Ag Verfahren zur Herstellung von Oxazolinen
BE790569A (fr) * 1971-10-27 1973-04-26 Syntex Corp Agents cardiovasculaires a base de thiazoles
HU167760B (es) * 1972-10-20 1975-12-25
HU167262B (es) * 1972-12-22 1975-09-27
CH585693A5 (es) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
US4237304A (en) * 1978-10-26 1980-12-02 The Dow Chemical Company Oxazolinium salts and method of preparation

Also Published As

Publication number Publication date
EP0007605B1 (de) 1982-09-15
EP0007605A1 (de) 1980-02-06
DK237588A (da) 1988-05-02
JPH0152391B2 (es) 1989-11-08
JPS63253078A (ja) 1988-10-20
US4391980A (en) 1983-07-05
ATE1547T1 (de) 1982-09-15
JPS6364408B2 (es) 1988-12-12
JPS5520785A (en) 1980-02-14
DE2963675D1 (en) 1982-11-04
FI69051B (fi) 1985-08-30
DK318379A (da) 1980-01-29
FI792337A (fi) 1980-01-29
FI69051C (fi) 1985-12-10
CA1132560A (en) 1982-09-28
AU529335B2 (en) 1983-06-02
AU4925879A (en) 1980-01-31
US4294966A (en) 1981-10-13
DK237588D0 (da) 1988-05-02

Similar Documents

Publication Publication Date Title
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
SE7900513L (sv) Forfarande for framstellning av oligoimider
ES482806A1 (es) Procedimiento para la inversion de la configuracion en com- puestos opticamente activos
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
SE8700506D0 (sv) Fenoxialkansyraestrar
SE8405123D0 (sv) Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
DE3362908D1 (en) Process for preparing trithiocarbonic acid diesters
KR880009010A (ko) 신규한 테트라히드로 푸란의 5-옥시 유도체의 제조방법
GB1061473A (en) Bicyclic sulphur containing olefines
ES546366A0 (es) Procedimiento para preparar derivados de 1,6-naftiridina
ES8104213A1 (es) Procedimiento para la preparacion de acido 4,4'dinitro es- tilben-2,2'-disulfonico y sus sales
SE8402649D0 (sv) Framstellning av 1,8-dihydroxi-10-acyl-9-antroner
ES8307236A1 (es) Un procedimiento para la preparacion de ranitidina.
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
DE68922344D1 (de) Herstellung von Enantiomeren des Dropropizins.
SE7702907L (sv) Forfarande for framstellning av nya sandwicinderivat
ES485801A1 (es) Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados
ES8305341A1 (es) "procedimiento de preparar derivados sulfimida de acido n-carbamoilbenzoico".
SE7501801L (es)
ES476164A1 (es) Procedimiento para la preparacion de nuevos derivados espec-tinomicinicos.
ES8307803A1 (es) Procedimiento de preparar trimetoxibenzoatos de apovincaminol substituidos con efecto inhibidor de las fosfodiestebasas.
ES461846A2 (es) Un procedimiento para la preparacion de acidos carboxilicos alfa-cetonicos.
KR830002691A (ko) 아미노벤조산 유도체의 제조방법
KR830000250A (ko) 세팔로스포린 유도체 및 그 제조법